News
The data may change how patients are treated following a diagnosis for advanced triple-negative breast cancer, one expert ...
5d
MedPage Today on MSNFirst-Line Keytruda-Trodelvy Boosts PFS in Triple-Negative Breast CancerCHICAGO -- Combining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line ...
A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...
From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...
New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...
At the crossroads of innovation and equity, Josette Gbemudu and Merck are helping rewrite the narrative for breast cancer ...
4don MSN
In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus ...
Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...
The "Fore The Fight: One Tough Titty Charity Golf Outing" is June 20 at Boulder Creek Golf Club. Foursomes can still sign up ...
Explore how cutting-edge agents like alpelisib, capivasertib, MEK and ERK inhibitors, and JAK inhibitors are reshaping the ...
Breast cancer survivor Ashley Siegenthaler says T.W.I.G.S was there when she needed help. Click to learn more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results